Carsten Thiel is CCO & VP at ALEXION PHARMACEUTICALS INC (ALXN). They have made 12 open-market trades across 1 company since 2015, most recently 2017-02-28.
CIK 0001633582
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALXN | 33,860 | $6.2M |
Shares reported on the most recent Form 4, priced at the 2017-03-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALXN | SELL | 2017-02-28 | 2017-03-06 | $131.01 | $991K | -7.5% | -12.2% | -23.2% |
| ALXN | SELL | 2017-02-27 | 2017-03-01 | $131.20 | $9K | -6.7% | -9.4% | -26.9% |
| ALXN | SELL | 2017-02-06 | 2017-02-08 | $125.69 | $21K | +2.4% | +0.4% | -1.7% |
| ALXN | SELL | 2016-12-09 | 2016-12-13 | $130.00 | $300K | +16.2% | +25.4% | +13.9% |
| ALXN | SELL | 2016-10-14 | 2016-10-18 | $120.28 | $1.1M | +12.0% | +1.5% | +11.7% |
| ALXN | SELL | 2016-10-03 | 2016-10-05 | $122.41 | $4K | -4.1% | +3.5% | -1.6% |
| ALXN | SELL | 2016-09-12 | 2016-09-14 | $128.67 | $415K | -2.0% | -6.8% | -13.4% |
| ALXN | SELL | 2016-09-06 | 2016-09-08 | $125.94 | $126K | +2.7% | -1.8% | -2.1% |
| ALXN | SELL | 2016-02-29 | 2016-03-01 | $138.91 | $8K | -6.9% | -6.9% | +0.9% |
| ALXN | SELL | 2016-02-16 | 2016-02-18 | $143.49 | $27K | +6.0% | -7.9% | +0.0% |
| ALXN | SELL | 2015-11-10 | 2015-11-12 | $173.34 | $520K | -15.6% | -1.2% | -25.8% |
| ALXN | SELL | 2015-09-10 | 2015-09-10 | $169.18 | $137K | -15.6% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.